SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Sick Visit — Friedrich Nietzsche

PatientFriedrich Nietzsche
Date of birth1989-10-15
IdentifiersMRN HR-NI019-SYN; SSN (made up) 000-19-5523
Document date2026-08-04
AuthorKonrad Ellison-Mbatha, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Flashes of light and a new floater in the right eye since last evening. [S]

History of Present Illness

Mr. Nietzsche asked for a same-day visit because last evening he began to see brief arcs of light at the outer edge of the right eye's vision when he moved his eyes, most noticeable in dim light, and this morning a cobweb-like floater that drifts when he looks around. There is no shadow or curtain, no loss of vision beyond his usual poor right eye, and no pain. He has no headache with it, and it is unlike his migraine attacks, which have never had a visual aura. He is in the third week of the butalbital taper, taking one tablet every other day, and had his first galcanezumab injection two weeks ago. He has had no injury to the eye. [S]

ElementDetail
OnsetLast evening
LocationRight eye only, outer field
DurationFlashes of a second or less, repeatedly, since last evening; floater since this morning
CharacterArcs of light with eye movement; a cobweb-like floater
SeverityNot painful; alarming to him
TimingWith eye movement, worse in dim light
ContextHigh myopia; poor right eye; third week of the taper
Modifying factorsNot affected by covering the left eye
Associated signs and symptomsNo headache, curtain, shadow, pain or injury

Review of Systems

SystemResultFinding
EyesPositiveFlashes and a floater in the right eye; no curtain, pain or redness
NeurologicalNegativeNo headache with the symptoms; no weakness, numbness or speech change
ConstitutionalNegativeNo fever

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, one or two tablets as needed for headache, taken on about 16 days a month, up to four tablets a day (prescribed abroad)One or two tablets as needed, about 16 days a month, up to four a dayOral route2025-11-03 to 2026-07-21stoppedS
Ibuprofen 200 mg oral tablet, two tablets as needed for headache on days without the combination tablets, about 4 days a month (over the counter)Two tablets as needed, about 4 days a monthOral route2025-11-03 to 2026-07-21stoppedS
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, scheduled taper: one tablet twice a day for 7 days, then one tablet a day for 7 days, then one tablet every other day for 7 days, then stopScheduled taper over three weeks: twice a day, then once a day, then every other day, then stop; not for extra dosesOral route2026-07-21 to 2026-08-10completedS
Naproxen 500 mg oral tablet, one tablet with food at the start of a migraine attack, may repeat once after 12 hours; no more than two days a weekOne tablet at attack onset, may repeat once after 12 hours; no more than two days a weekOral route2026-07-21activeS
Metoclopramide 10 mg oral tablet, one tablet with the acute medicine when a migraine attack brings nausea or vomiting; no more than two days a weekOne tablet with the acute medicine when nausea is present, no more than once a dayOral route2026-07-21activeS
Galcanezumab 120 mg/mL auto-injector, 240 mg (two injections) under the skin as a first loading dose, then 120 mg once a month, for chronic migraine preventionLoading dose of 240 mg (two injections) on the first day, then 120 mg every four weeksSubcutaneous route2026-07-21activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-04Body height174cmS
2026-08-04Body weight66.4kgS
2026-08-04Body mass index (BMI) [Ratio]21.9kg/m2S
2026-08-04Systolic blood pressure116mm[Hg]S
2026-08-04Diastolic blood pressure74mm[Hg]S
2026-08-04Heart rate66/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-08-04; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 116/74, pulse 66
EyesVisual acuity with contact lenses 20/100 right and 20/20 left, unchanged; right pupil 1 mm larger, both reacting briskly, no afferent defect; confrontation fields full; no redness. Dilated examination by the eye service: a Weiss ring in the right eye; no retinal break, detachment, vitreous hemorrhage or pigment in the anterior vitreous; the known myopic changes at the right macula are unchanged; left eye unchanged
NeurologicalNormal

Problems

ProblemClinical statusVerificationCodeProvenance
Frequent disabling headaches on about 20 days a month, with nausea, vomiting and light sensitivity, mostly right-sided, since childhood and more frequent over the past year, with a combination headache tablet containing butalbital taken on about 16 days a month; under evaluation with a headache diary, MRI, syphilis serology and a headache medicine consultationresolvedconfirmed R51.9S — Synthetic presenting problem anchored to his documented headaches; superseded when the consultation confirmed chronic migraine with medication overuse headache.
Chronic migraine without aura (15 or more headache days a month for more than three months, at least 8 with migraine features); ICHD-3 criteria met in a two-week diary; MRI of the brain normal; synthetic modern diagnosis linked to his documented headaches, which historians interpret differentlyactiveconfirmed G43.709S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0014), so this is not a claim about his real diagnosis.
Medication overuse headache from a butalbital, acetaminophen and caffeine combination on 10 or more days a month for more than three months, with ibuprofen on other days; resolved after a three-week taper and withdrawalactiveconfirmed G44.40S — Synthetic diagnosis made at the consultation, anchored to his documented use of many medicines and sedatives; not a claim about his real medicines.
High myopia in both eyes, much worse in the right eye, since early childhood, with long-standing poor vision in the right eye and unequal pupils; comprehensive eye examination bookedactiveconfirmed H52.13S — Synthetic modern coding of his documented severe myopia.
Pathologic (degenerative) myopia of the right eye with patchy chorioretinal atrophy of the macula, a posterior staphyloma and a tilted optic disc; no choroidal neovascularization on OCT; best corrected vision 20/100 in the right eyeactiveconfirmed H44.2E1S — Synthetic finding of the comprehensive eye examination, anchored to his documented poor right eye and the retrospective reading of it as myopic degeneration; not a claim about his real eyes.
Chronic insomnia, with difficulty falling asleep and early waking, worse on headache nights; no sleep medicine at intakeactiveconfirmed G47.00S — Synthetic sleep problem anchored to his documented severe insomnia; not a claim about his real sleep.
Acute posterior vitreous detachment of the right eye, with flashes and a floater, without a retinal break, detachment or vitreous hemorrhage on dilated examination, in an eye with pathologic myopiaactiveconfirmed H43.811S — Synthetic acute eye problem in a highly myopic eye; not a historical claim.

Assessment and Plan

Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern (2025)

Follow-up: Four-week review in two weeks. Same-day eye care for the warning symptoms above. Next scheduled visit 2026-08-18: four-week review after starting galcanezumab and the taper: withdrawal, headache days, acute medicine and the second injection. [S]